Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development and commercialization of novel. Ultragenyx Pharmaceutical (NASDAQ:RARE) Stock Quotes, Forecast and News Summary ; 52 Wk Range, - ; Market Cap, $B ; P/E Ratio, - ; Dividend Yield, -. Ultragenyx Pharmaceutical Inc. analyst ratings, historical stock prices, earnings estimates & actuals. RARE updated stock price target summary. A high-level overview of Ultragenyx Pharmaceutical Inc. (RARE) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals. Ultragenyx Pharmaceutical, Inc. engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic.
Ultragenyx Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants This site uses cookies to provide you with a more responsive and. See the latest Ultragenyx Pharmaceutical Inc stock price (RARE:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Ultragenyx Pharmaceutical Inc RARE:NASDAQ ; Open ; Day High ; Day Low ; Prev Close ; 52 Week High Ultragenyx Pharmaceutical traded at $ this Friday September 6th, decreasing $ or percent since the previous trading session. Looking back, over. The average one-year price target for Ultragenyx Pharmaceutical Inc. is $ The forecasts range from a low of $ to a high of $ A stock's. Denali Therapeutics Inc. $ DNLI ; ROIV. $ ROIV ; Intellia Therapeutics Inc. $ NTLA ; Madrigal Pharmaceuticals Inc. $ MDGL ; Summit. The average price target for Ultragenyx Pharmaceutical is $ This is based on 19 Wall Streets Analysts month price targets, issued in the past 3 months. Get Ultragenyx Pharmaceutical Inc (arkada2007.ru) real-time stock quotes, news, price and financial information from Reuters to inform your trading and. Get Ultragenyx Pharmaceutical Inc (UP0-FF:Frankfurt Stock Exchange) real-time stock quotes, news, price and financial information from CNBC. Ultragenyx Pharmaceutical Inc. (RARE) ; Aug 16, , , , , ; Aug 15, , , , , On average, Wall Street analysts predict that Ultragenyx Pharmaceutical's share price could reach $ by Aug 5, The average Ultragenyx Pharmaceutical.
Ultragenyx Pharmaceutical Inc. (arkada2007.ru): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Ultragenyx Pharmaceutical. RARE | Complete Ultragenyx Pharmaceutical Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. The company's common stock is listed on The NASDAQ Global Select Market under the ticker symbol "RARE." Ultragenyx estimates net proceeds from the offering to. Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company. The Company is focused on the identification, acquisition, development, and commercialization. Discover real-time Ultragenyx Pharmaceutical Inc. Common Stock (RARE) stock prices, quotes, historical data, news, and Insights for informed trading and. Ultragenyx Pharmaceutical Price Targets · Current$ · Target %$ The Investor Relations website contains information about Ultragenyx Pharmaceutical Inc.'s business for stockholders, potential investors, and financial. Discover real-time Ultragenyx Pharmaceutical Inc. Common Stock (RARE) stock prices, quotes, historical data, news, and Insights for informed trading and. Ultragenyx Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants This site uses cookies to provide you with a more responsive and.
You can buy Ultragenyx Pharmaceutical Inc (RARE) stock and many other stocks or ETFs on Stash. Purchase fractional shares with any dollar amount. Ultragenyx Pharmaceutical Inc. ; Open. $ Previous Close$ ; YTD Change. %. 12 Month Change. % ; Day Range · 52 Wk Range - The current price of RARE is USD — it has increased by % in the past 24 hours. Watch Ultragenyx Pharmaceutical Inc. stock price performance more. Ultragenyx Pharmaceutical Inc (RARE) USD ; Trade low · $ ; Year low · $ ; Previous · $ ; Volume · n/a ; Dividend yield · %. Ultragenyx Pharmaceutical Price Targets · Current$ · Target %$
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products.
Cramer: This biotech stock could be worth over $100 billion on an FDA approval